Align Technology
$172.91
▲ +2.22%
+$3.75
NASDAQ · Healthcare · Medical Instruments & Supplies
· price updated 9h ago
ALGN · NASDAQ · Healthcare · Medical Instruments & Supplies · price updated 9h ago
$172.91
▲ +2.22% · +$3.75 today
AI research · $172.91
Operating record
Capital structure
Valuation
Forward P/E
Price against expected earnings
Favorable · 19% below Sector avg · favorable
14.32x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.93x
Price / FCF
Price against free cash generation
Strong · Under 20x free cash flow
18.55x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
14.57x
Quality
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
17.3%
ROE
Profit generated from shareholder equity
Middle ground · Roughly in line with sector
10.2%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.02x
Current ratio
Short-term assets against liabilities
Reasonable · Assets still cover near-term liabilities
1.40x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $12.11B | 29.4 | +4.4% | 64 | |
| $10.69B | 18.4 | +23.5% | 78 | |
| $4.88B | 20.3 | +10.3% | 77 | |
| $31.49B | 32.9 | +15.5% | 77 | |
| $1.08T | 41.4 | +47.4% | 76 |
US stock research
Align Technology — US core universe (S&P 500 sourced). ALGN was +2.2% in the latest available session at $172.91. Its reported market value was $12.11B with a trailing P/E of 29.4. Latest reported revenue was $4.14B, changing +4.4% year over year, with $413.58M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.